Anvisa Investigates 65 Deaths Linked to Weight Loss Pens (Ozempic, Wegovy, Mounjaro)

Investigations are intensifying into the safety of weight-loss medications, commonly known as “skinny pens,” as Brazil’s national health regulatory agency, Anvisa, investigates 65 reported deaths potentially linked to their use. The surge in reported adverse events and fatalities has prompted increased scrutiny of these drugs, particularly those containing semaglutide, liraglutide, and tirzepatide, and raised concerns … Read more